Feasibility Study to Determine the Effects of Phrenic Nerve Stimulation in Patients With Periodic Breathing

Clinical trial NCT00909259 · COMPLETED

Trial details

NCT number: NCT00909259
Sponsor: Respicardia, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sleep Disordered Breathing Cheyne-Stokes Respiration Sleep Apnea

Start date: 2007-10-01
Primary completion: 2010-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.